Buteyko Method for Children With Asthma

Not Applicable

Completed

• Conditions: Child; Asthma; Breathing Exercises
• Interventions: Other: Buteyko; Other: Asthma education

• Registration Number: NCT02720380
• Lead Sponsor: Universidade Federal do Rio Grande do Norte

Brief Summary

This study has the aim to assess the effectiveness of the Buteyko method as an adjunct therapy in the treatment of children with asthma.

Detailed Description

Children from 7 to 12 years old with asthma diagnose will be included. Children in the intervention group will perform 6 sessions (twice a week) of treatment with the Buteyko Method. Children assigned to the control group will receive, along with their parents, educational interventions in relation to asthma. The investigators will assess quality of life by the PAQLQ (Paediatric Asthma Quality of Life Questionnaire), pulmonary function (spirometry) and the six-minute walk test. Vital signs, pulmonary auscultation and oxygen peripheral saturation will also be assessed during the tests. In addition, information will be collected on the numbers of hospitalizations, occurence of absence in school due to exacerbation of the disease, asthma symptoms and Beta2-agonists usage .

Study Timeline

• Study Start: 2015-07
• Study First Submitted: 2016-03-07
• Study First Submitted QC: 2016-03-21
• Study First Posted: 2016-03-25
• Primary Completion: 2016-05
• Study Completion: 2016-05
• Status Verified: 2017-01
• Last Update Submitted: 2017-01-20
• Last Update Posted: 2017-01-24

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 32

Inclusion Criteria

• Children from 7 up to 12 years old with asthma diagnose;
• Regular inhaled corticosteroids with no change in dose in the preceding 4 weeks;
• Children cannot present: other respiratory disease (such as cystic fibrosis, bronchiectasis, tuberculosis), retinal detachment, hypertensive crisis, congenital heart defect, pulmonary edema, history of lobectomy or lung segmentectomy, respiratory infections 15 days prior to the evaluations.

Exclusion Criteria

• Children that are not able to perform some of the necessary procedures;
• Give up participating in the research and present acute symptoms of respiratory tract during the assessments.

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Arm && Interventions

Group	Intervention	Description
Buteyko	Buteyko	Children in the intervention group will perform 6 sessions (twice a week) of treatment with the Buteyko Method.
Asthma education	Asthma education	Children assigned to the control group will receive, along with their parents, educational interventions in relation to asthma.

Primary Outcome Measures

Name	Time	Method
Change in Quality of life (questionnaire)	Baseline and three weeks later	Quality of life will be assessed by the Pediatric Asthma Quality of Life Questionnaire (PAQLQ).

Secondary Outcome Measures

Name	Time	Method
Occurrence of absences in school	Through study completion, an average of three weeks
Change in pulmonary function (spirometry)	Baseline and three weeks later	Measured parameters (which will be expressed as percent predicted): FVC, FEV1, FEV1/FVC, FEF25-75%, PEF. PEF will be expressed as L/min.
Change in the Six-minute walk test distance	Baseline and three weeks later
Number of visits to the emergency room	Through study completion, an average of three weeks
Occurrence of exacerbations	Through study completion, an average of three weeks	Occurrence of asthma exacerbations or allergy episodes
Occurrence of Beta2-agonists usage	Through study completion, an average of three weeks

Trial Locations

Locations (1)

Universidade Federal do Rio Grande do Norte (UFRN); 🇧🇷 Natal, Rio Grande do Norte, Brazil